GlassScriptPhysician profile
Adam Truong
NPI 1376032342
$7,596.01
in general payments reported to CMS, 2019-2025
20 companies · $524 in 2025
The $524 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264 · 2020: $52.87 · 2021: $147 · 2022: $2,061 · 2023: $3,356 · 2024: $1,191 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,791 · Travel and Lodging: $1,280 · Education: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,791.30 |
| Travel and Lodging | $1,280.10 |
| Education | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,302.30 | 2019-2023 | Davinci Xi, Da Vinci Surgical System |
| Medtronic, INC. | $1,717.20 | 2022-2025 | Interstim, Eea, Aquamantys(Tm) |
| Boston Scientific Corporation | $381.23 | 2023-2025 | General - Therapies, Orise |
| Aroa Biosurgery Incorporated | $362.68 | 2022-2025 | |
| Kerecis Limited | $245.90 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Ethicon US, LLC | $221.97 | 2023-2025 | Contour, Enseal, Echelon; Endopath |
| Davol INC. | $220.30 | 2022-2025 | Phasix Mesh |
| Conmed Corporation | $175.00 | 2023 | Airseal |
| Medical Device Business Services, INC. | $136.00 | 2021-2022 | |
| Vioptix INC | $131.08 | 2024 | T. Ox Tissue Oximeter |
| Inspire Medical Systems, INC. | $130.61 | 2024 | Inspire |
| Janssen Pharmaceuticals, INC | $124.98 | 2019 | |
| Baxter Healthcare | $118.06 | 2023 | Tisseel |
| Ferring Pharmaceuticals INC. | $105.98 | 2023 | Rebyota |
| Myriad Genetic Laboratories, INC. | $93.21 | 2023 | Myrisk |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $35.36 | 2024 | Axonics |
| Tela Bio, INC. | $26.92 | 2024 | Ovitex 2s |
| Olympus America INC. | $24.60 | 2025 | Endoclot Sis, Single Use Electrosurgical Knife Kd-655 |
| Coopersurgical, INC. | $23.39 | 2024 | Fisherbrand Disposable Liquid Infant Heel Warmer |
| Vertex Pharmaceuticals Incorporated | $19.24 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Truong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.